Results 81 to 90 of about 19,293 (297)

Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC [PDF]

, 2018
Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric ...
Brandl, Andreas, Feist, Mathilde, Katou, Shadi, Pratschke, Johann, Rau, Beate, Raue, Wieland   +5 more
core   +1 more source

Prospective case‐control cohort analysis of two‐day/two‐stage pelvic exenteration surgery: Safety, feasibility, acceptability and medium‐term outcomes

Colorectal Disease, Volume 28, Issue 1, January 2026.
Abstract Aim Pelvic exenteration (PE) is the only curative option for extensive pelvic cancers. Advances have facilitated increasingly complex resectional and reconstructive components, including per‐operative oncological adjuncts such as intraoperative radiotherapy.
Charles T. West, Yousif Salem, Siddharth Jain, Lewis Matthews, Julian Smith, Marios Nicolaou, Hideaki Yano, Malcolm A. West, Alex H. Mirnezami   +8 more
wiley   +1 more source

Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer [PDF]

, 2023
Gopika SenthilKumar, Jennifer E. Merrill, Ugwuji N. Maduekwe, Jordan M. Cloyd, Keith F. Fournier, Daniel E. Abbott, Nabeel Zafar, Sameer H. Patel, Fabian M. Johnston, Seán Dineen, Joel Baumgartner, Travis E. Grotz, Shishir K. Maithel, Mustafa Raoof, Laura Lambert, Ryan J. Hendrix, Anai N. Kothari   +16 more
openalex   +1 more source

Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers

Journal of Surgical Oncology, Volume 132, Issue 5, Page 789-809, October 2025.
ABSTRACT Peritoneal malignancy often indicates disruptions in multiple physiological systems resulting from widespread cancer. The heterogenous origin and dynamic nature of peritoneal cancer make it difficult to treat with standard approaches that fit into guidelines.
Ada I. Ozcan, Arianexys Aquino López, Mary K. McKenna, Malcolm K. Brenner, Alastair M. Thompson   +4 more
wiley   +1 more source

THE ROLE OF HIPEC IN PERITONEAL CARCINOMATOSIS DUE TO COLORECTAL CANCER – PROCEDURE, COMPLICATIONS, AND LITERATURE EVIDENCE

Journal of Surgical Sciences, 2020
Cytoreductive surgery and HIPEC have become de pillars of treatment in advanced, metastatic colorectal cancer. This state of evolution of the disease was considered terminal just a few years ago.
Iulian Slavu, Adrian Tulin, Bogdan Socea, Dan Nicolae Păduraru, Vlad Braga, Lucian Alecu   +5 more
doaj   +1 more source

Peritoneal carcinosis of ovarian origin [PDF]

, 2010
Epithelial ovarian cancer (EOC) is the second most common genital malignancy in women and is the most lethal gynecological malignancy, with an estimated five-year survival rate of 39%.
Fagotti, A, Fanfani, F, Gallotta, V, Naldini, A, ROMANO, Federico, Rossitto, C, Scambia, G., Vigliotta, M   +7 more
core   +2 more sources

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines

Cells, 2020
Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment with curative intent for peritoneal metastasis of colorectal cancer (CRC).
R. F. Helderman, Daan R Löke, J. Verhoeff, H. Rodermond, Gregor G W van Bochove, M. Boon, Sanne van Kesteren, J. J. Garcia Vallejo, H. P. Kok, P. Tanis, N. Franken, J. Crezee, A. Oei   +12 more
semanticscholar   +1 more source

Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis

, 2019
Recent advances in locoregional chemotherapy have opened the door to new approaches for the clinical management of peritoneal carcinomatosis (PC) by facilitating the delivery of anti-neoplastic agents directly to the tumor site, while mitigating adverse ...
Ceelen, Wim, De Smedt, Stefaan, Remaut, Katrien, Shariati, Molood, Willaert, Wouter   +4 more
core   +1 more source

Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer [PDF]

, 2019
Patients with advanced ovarian cancer develop recurrence despite initial treatment response to standard treatment of surgery and intravenous/intraperitoneal (IP) chemotherapy, partly due to a limited peritoneal exposure time of chemotherapeutics ...
Ceelen, Wim, De Clercq, Kaat, De Wever, Olivier, Descamps, Benedicte, Hoorens, Anne, Vermeulen, An, Vervaet, Chris, Xie, Feifan   +7 more
core   +2 more sources

Closed‐Incision Negative Pressure Therapy: Scoping Review and Multidisciplinary Consensus Recommendations of the Spanish Observatory of Infection in Surgery

International Wound Journal, Volume 22, Issue 10, October 2025.
ABSTRACT Surgical site infections (SSI) and surgical site complications (SSC) significantly impact surgery outcomes, increasing hospital stays and mortality rates, and negatively affecting patients' quality of life. Closed‐incision negative pressure therapy (ciNPT) emerged as a prophylactic strategy to reduce these complications.
Josep M. Badia, Inés Rubio‐Pérez, Carlos Morales‐Pérez, José Bueno‐Lledó, Laura M. Rodríguez‐Lorenzo, Joan Sancho, Oliver Marín‐Peña, Susana López, Jaume Masià, José M. Balibrea   +9 more
wiley   +1 more source